Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
21.10.23 | AstraZeneca: IMFINZI (durvalumab) plus LYNPARZA (olaparib) reduced the risk of disease progression or death by 45% vs. chemotherapy in advanced or recurrent endometrial cancer | 795 | Business Wire | IMFINZI reduced the risk of disease progression or death by 29% vs. chemotherapy First Phase III trial to demonstrate clinical benefit of immunotherapy plus PARP inhibition in advanced or recurrent... ► Artikel lesen | |
21.10.23 | AnHeart Therapeutics' Investigational Medicine Taletrectinib Shrank Tumors in More Than 90 Percent of People With ROS1-Positive Non-Small Cell Lung Cancer Who Were ROS1 TKI Naïve in Global Pivotal TRUST-II Trial | 556 | Business Wire | Taletrectinib also shrank tumors in 57 percent of people with ROS1-positive NSCLC who had previously been treated with a ROS1 TKI in the trial Taletrectinib continues to be generally well tolerated... ► Artikel lesen | |
21.10.23 | Aviapartner Extends Footprint Through Joint Venture With South Africa | 515 | Business Wire | Aviapartner, leading Airport Ground Services group in Europe, enters a Joint Venture with Colossal to serve airlines and passengers in South Africa. With this partnership, the Belgium headquartered... ► Artikel lesen |
Suchbegriffe der letzen 24 h | Anzahl |
---|---|
EVOTEC | 1.647 |
BAYER | 1.409 |
NEL | 1.323 |
TUI | 1.187 |
PLUG POWER | 1.157 |
NOVAVAX | 1.140 |
SIEMENS ENERGY | 1.106 |
MERCEDES-BENZ | 1.084 |
PALANTIR TECHNOLOGIES | 765 |
NVIDIA | 724 |
ALLIANZ | 721 |
RWE | 684 |
DEUTSCHE BANK | 664 |
BYD | 627 |
BASF | 578 |
DEUTSCHE LUFTHANSA | 577 |
RHEINMETALL | 545 |
TESLA | 531 |
VOLKSWAGEN | 514 |
INFINEON | 496 |
COMMERZBANK | 492 |
AIXTRON SE | 473 |
NORDEX | 473 |
STANDARD LITHIUM | 457 |
RENK GROUP | 453 |